QQ客服 官方微博 反馈留言

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Prognostic value of receptor status conversion following neoadjuvant chemotherapy in breast cancer patients: a systematic review and meta-analysis 期刊论文 2019 作者:  Li Chao;  Fan Hongwei;  Xiang Qian;  Xu Ling;  Zhang Zhuo 收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03 Breast cancer  Neoadjuvant chemotherapy  Prognosis  Receptor   Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial 期刊论文 2018, 卷号: 6, 期号: 9, 页码: 681-690 作者:  Wang, Zhijie;  Cheng, Ying;  An, Tongtong;  Gao, Hongjun;  Wang, Kai 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03 Distinct MET Protein Localization Associated With MET Exon 14 Mutation Types in Patients With Non-small-cell Lung Cancer 期刊论文 2018, 卷号: 19, 期号: 4, 页码: E391-E398 作者:  Qiu, Tian;  Li, Weihua;  Zhang, Tongtong;  Xing, Puyuan;  Huang, Wenting 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 Chinese  Immunohistochemistry  MET exon 14 skipping  Sequencing  Targeted therapy   Response to crizotinib in advanced &ITALK&IT-rearranged non-small cell lung cancers with different &ITALK&IT-fusion variants 期刊论文 2018, 卷号: 118, 页码: 128-133 作者:  Li, Yan;  Zhang, Tongtong;  Zhang, Jing;  Li, Wenbin;  Yuan, Pei 收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03 ALK translocation  Non-small cell lung cancer  Crizotinib  Next-generation sequencing  Variants   A MET Inhibitor in the Treatment of Metastatic Non-Small Cell Lung Cancer with MET Amplification 期刊论文 2017, 卷号: 12, 期号: 1, 页码: S1276-S1276 作者:  Zhang, Tongtong;  Li, Junling 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03 metastatic non-small cell lung cancer  EGFR  MET inhibitor   Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy 期刊论文 2017, 卷号: 29, 期号: 5, 页码: 411-418 作者:  Wang, Jiani;  Li, Qing;  Xu, Binghe;  Zhang, Tongtong;  Chen, Shanshan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Duloxetine  FACT-Tax Scales  paclitaxel  peripheral neuropathy   Phase I/II Study of AC0010, Mutant Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation 期刊论文 2017, 卷号: 12, 期号: 1, 页码: S437-S438 作者:  Wu, Yi Long;  Zhou, Qing;  Liu, Xiaoqing;  Zhang, Li;  Zhou, Jianying 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Phase I/II study  NSCLC  T790M  AC0010   Clinical Data from the Real World: Efficacy of Crizotinib in Chinese Patients with Advanced ALK plus Non-Small Cell Lung Cancer and Brain Metastases 期刊论文 2017, 卷号: 12, 期号: 1, 页码: S944-S944 作者:  Wang, Shouzheng;  Xing, Puyuan;  Li, Junling;  Hao, Xuezhi;  Zhang, Tongtong 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 non-small cell lung cancer  Brain metastasis  crizotinib  Real world   Phase I study of QLNC120, a novel EGFR and HER2 kinase inhibitor, in pre-treated patients with HER2-overexpressing advanced breast cancer 期刊论文 2017, 卷号: 8, 期号: 22, 页码: 36750-36760 作者:  Zhang Tongtong;  Li Qing;  Chen Shanshan;  Luo Yang;  Fan Ying 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 QLNC120  tyrosine kinase inhibitor  Phase I  HRAS   Response to crizotinib in advanced ALK-rearranged NSCLCs with different variants and abundance of ALK-fusion alleles 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20 作者:  Ying, Jianming;  Li, Yan;  Zhang, Tongtong;  Li, Wenbin;  Xing, Pu-Yuan 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04